The anti-tumor effects of these cells in vivo appears to be, in addition to IFN-g, IL-12, and Fas ligand, dependent on NKG2D as in vivo blockade of NKG2D significantly reduces the anti-tumor efficacy (62). Here, FASLG is linked to neoplasm.